ERP Soft Systems Ltd
530909ERP Soft Systems Ltd is cheap for a reason. The P/E sits at the 16th percentile of its own range, and the quarters are still getting worse.
The sharpest disagreement: annual EPS moved +11.6% against a −63.6% price move — the market has not yet caught up with the delivery.
The price is in a downtrend (32 weeks in) while the P/E sits at the 16th percentile of its own 9-year range. Underneath, the last four quarters read deteriorating — profit −25.0% year on year, and 82% of the last 3 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
ERP Soft Systems Ltd trades at ₹47.3, in a downtrend and 32 weeks into that stage. That is −47.7% against its own 200-day average. It sits at 3% of a 52-week range of ₹44 to ₹144. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (50 weeks and counting).
Today the stock is in a downtrend — week 32 of stage 4, confirmed. At ₹47.3 it trades −47.7% versus its 200-day average and sits at 3% of its 52-week range (₹44–₹144).
Against the market, two honest reads. Cumulative: over the last 9.2 years the stock moved −32% while the NIFTY 500 moved +179% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (50 weeks and counting; last ahead the week of 2025-04-04) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
ERP Soft Systems Ltd trades at 74.9× P/E, near the bottom of its own range — cheaper only 16% of the time. Its long-run median P/E is 151.5×, measured across 9.2 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 74.9× is near the bottom of its own range — cheaper only 16% of the time, against a long-run median of 151.5× measured over 9.2 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +11.6% against a −63.6% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 5y, of the +0.0%/yr price move, ~−1.5%/yr came from earnings growth and ~+1.5 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is low against its own past, so the story rests on the earnings line underneath it, not the multiple.
What the price assumes This reading works the multiple backwards. It asks one question: what yearly rate of profit growth is a buyer at the market price already paying for? The number is the growth rate that makes eleven years of profit — six years growing, then five fading — add up to that day's market price, once each year is discounted at 11% a year.
At its price on 13 June 2026, ERP Soft Systems Ltd was priced for profit growth of about 37.0% a year. Profit itself has compounded −7.8% a year over the past 10 years. The market pays that at 74.9× P/E, the 16th percentile of its own 9-year range.
What the two numbers say together. The multiple is low against its own past, and the growth the price is paying for is above what this company has actually delivered. Both readings sit on the same earnings, so they are one reading rather than two. A multiple that looks low because earnings fell is not the same thing as a low bar to clear.
How to hold this number: it is a reading of one day's price, taken on 13 June 2026, not a running figure. A higher price is paying for more growth and a lower price for less, so it moves whenever the price does, and this page does not restate it between measurements. Every other number on this page is read off the live quote.
Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
ERP Soft Systems Ltd reads as mixed on its fundamental arc. Mixed — no clean majority across the growth curves, ROCE holding at 1.6% — the per-curve reads carry the story. The read is built from 10 quarters across 3 curves, on partial evidence.
Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | −17.5% | −11.1% | −0.9% | −4.2% |
| Profit | +11.8% | −1.7% | +6.3% | −7.8% |
| EPS | +11.6% | −2.0% | +6.5% | −7.9% |
| Share price | −63.6% | −15.7% | +0.0% | — |
4-Factor Sector Score
44.3/100 — rank 63 of 64 in IT - Software · 41% evidence confidence · provisional, ranked below fully-evidenced peers
ERP Soft Systems Ltd scores 44.3 out of 100 against the 64 companies it is compared with in IT - Software, ranking 63. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
The four contributions add to the total exactly: 19.8 + 8 + 8.9 + 7.6 = 44.3. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
ERP Soft Systems Ltd reported ₹2.4 Cr of revenue in the Dec 25 quarter, −7.5% year on year. Over 10 years it has compounded at −4.2% a year. The last full year, FY25, came in at ₹9.7 Cr. The last four reported quarters add to ₹10.8 Cr.
FY25 revenue came in at ₹9.7 Cr (−17.5% on the year), capping 10 years at −4.2% compound. The latest quarter (Dec 25) printed ₹2.4 Cr, −7.5% year on year.
Pace check: the last four quarters averaged +21.2% growth against the decade's −4.2% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +19.1% over the last 4 quarters against −13.2%/yr over the last 8 — accelerating; TTM profit +108.3% vs −3.8%/yr — accelerating.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
ERP Soft Systems Ltd's operating margin is 1.7% in the Dec 25 quarter, −1.1 percentage points against the same quarter a year ago. Across 12 fiscal years the operating margin has ranged −5.1% to 4.7%. The current quarter sits inside that band.
The latest quarter's operating margin is 1.7%, −1.1 pp against the same quarter a year ago. Across 12 fiscal years the operating margin has ranged −5.1%–4.7%.
🚨 Why the margin moved: operating margin went −1.1 pp year on year while gross margin went +0.0 pp — the loss came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
ERP Soft Systems Ltd earned ₹0.0 Cr of net profit in the Dec 25 quarter, −25.0% year on year. Full-year FY25 profit was ₹0.2 Cr. The 10-year compound rate is −7.8%. That is 1.3% of the quarter's revenue. The same quarter a year earlier earned ₹0.0 Cr.
Dec 25 profit was ₹0.0 Cr, −25.0% year on year. On the full year, FY25 printed ₹0.2 Cr (+11.8%), and the 10-year compound rate is −7.8%.
🚨 Why profit moved: revenue contributed −7.5% and the margin −1.1 pp — the quarter was revenue-led, with the margin roughly flat.
Pace comparison, last four quarters: profit +122.9% vs revenue +21.2%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 82% of ERP Soft Systems Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY25 that was ₹0.7 Cr of operating cash against ₹0.2 Cr of profit. After ₹0.0 Cr of capital spending, ₹1.0 Cr was left as free cash.
FY25: operating cash of ₹0.7 Cr against reported profit of ₹0.2 Cr, leaving free cash of ₹1.0 Cr after ₹0.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 82% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 82%: the cash cycle stretched 262 days between FY20 and FY25 — more of each rupee of profit waits inside the cycle before arriving.
Router verdict: no single sink dominates — the next section checks both the working-capital cycle and the capital spending.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
ERP Soft Systems Ltd's cash conversion cycle runs 451 days in FY25, up from 190 days in FY20. Capital spending ran ₹0.0 Cr over the last 3 years. At FY25 sales of ₹9.7 Cr each day of that cycle holds about ₹0.0 Cr, so roughly ₹12.0 Cr sits inside the business at any moment.
FY25: debtors at 451 days (an asset-light business — no inventory to speak of) — for a full cycle of 451 days, looser than FY20's 190.
In money terms: at FY25 sales of ₹9.7 Cr, each day of the cycle holds about ₹0.0 Cr — so the 451-day loop keeps roughly ₹12.0 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹0.0 Cr over the last 3 fiscal years. Capital work-in-progress stands at ₹0.0 Cr (FY25) — capacity paid for but not yet earning.
The synthesis: neither the cycle nor the build-out is hoarding the cash — the machine is reasonably clean.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
ERP Soft Systems Ltd earns a ROCE of 2% in FY25. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is 2.0% net margin on 0.40× asset turns.
FY25 ROCE is 2%.
Why the return is what it is — the wiring (FY25): 2.0% net margin × 0.40× asset turns × 1.35× balance-sheet leverage ≈ 1.1% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.
Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.
ERP Soft Systems Ltd carries ₹1.9 Cr of borrowings against ₹18.1 Cr of equity in FY25, a debt-to-equity of 0.11. Operating profit covers the interest bill 9×. Over 5 years borrowings went from ₹0.0 Cr to ₹1.9 Cr. Capital spending ran ₹0.0 Cr across the last 3 of those years.
FY25: borrowings of ₹1.9 Cr against equity of ₹18.1 Cr — a debt-to-equity of 0.11. Operating profit covers the interest bill 9×. Over 5 years borrowings went from ₹0.0 Cr to ₹1.9 Cr while capital spending ran ₹0.0 Cr in just the last 3 — part of the build-out is riding on borrowed money.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
No holder of ERP Soft Systems Ltd moved a full percentage point over the last two years — the register is quiet. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Promoters: +0.0 points over 8 quarters to 55.8%.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
ERP Soft Systems Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Coforge LtdCOFORGE | 76.7/100Favorable setup100% evidence | LEADER | 30.0/35 Revenue 35.7% · PAT 66.5% · OPM change 3 pp 100% evidence | 15.7/25 ROCE 23.5% · OPM 19% 100% evidence | 12.7/20 P/E 41.9× · PEG 0.57 100% evidence | 18.3/20 RS sector 11.9% · RS bench 15.3% · 1Y 12.8%12 of 12 weeks ahead 100% evidence |
| Exact sum: 30 + 15.7 + 12.7 + 18.3 = 76.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Silver Touch Technologies LtdSILVERTUC | 73.4/100Favorable setup93% evidence | LEADER | 30.2/35 Revenue 21.1% · PAT 86.4% · OPM change 8 pp 100% evidence | 17.4/25 ROCE 29.8% · OPM 22% 100% evidence | 10.2/20 P/E 63.7× · PEG 1.11 65% evidence | 15.6/20 RS sector 52.8% · RS bench 60.7% · 1Y 183.3%12 of 12 weeks ahead 100% evidence |
| Exact sum: 30.2 + 17.4 + 10.2 + 15.6 = 73.4 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 3NINtec Systems LtdNINSYS | 65.5/100Favorable setup80% evidence | LEADER | 20.2/35 Revenue 21.6% · PAT 18.8% · OPM change 4.2 pp 95% evidence | 21.8/25 ROCE 55% · OPM 25.9% 95% evidence | 9.2/20 P/E 40.9× · PEG — 15% evidence | 14.3/20 RS sector 40.8% · RS bench 46% · 1Y 77.8%12 of 12 weeks ahead 100% evidence |
| Exact sum: 20.2 + 21.8 + 9.2 + 14.3 = 65.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Cigniti Technologies LtdCIGNITITEC | 63.7/100Mixed-positive evidence79% evidence | 23.4/35 Revenue 14% · PAT 96.1% · OPM change 2 pp 56% evidence | 16.2/25 ROCE 34.1% · OPM 18% 75% evidence | 16.0/20 P/E 11.4× · PEG 0.61 100% evidence | 8.1/20 RS sector -9.4% · RS bench -15% · 1Y -16.2%0 of 12 weeks ahead to 2026-05-17 100% evidence | |
| Exact sum: 23.4 + 16.2 + 16 + 8.1 = 63.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Tech Mahindra LtdTECHM | 63.5/100Mixed-positive evidence94% evidence | BREAKING OUT | 21.2/35 Revenue 10.9% · PAT 14.3% · OPM change 3 pp 100% evidence | 16.2/25 ROCE 23.1% · OPM 17% 100% evidence | 10.6/20 P/E 30.1× · PEG 0.76 100% evidence | 15.5/20 RS sector 16% · RS bench 7.2% · 1Y 10.3%6 of 11 weeks ahead 70% evidence |
| Exact sum: 21.2 + 16.2 + 10.6 + 15.5 = 63.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Datamatics Global Services LtdDATAMATICS | 63.3/100Mixed-positive evidence94% evidence | BREAKING OUT | 21.1/35 Revenue 13.1% · PAT 1.9% · OPM change 4 pp 100% evidence | 16.1/25 ROCE 20.8% · OPM 20% 100% evidence | 11.2/20 P/E 20.2× · PEG 0.58 100% evidence | 14.9/20 RS sector 10.8% · RS bench 4.8% · 1Y -12.4%7 of 10 weeks ahead 70% evidence |
| Exact sum: 21.1 + 16.1 + 11.2 + 14.9 = 63.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Sasken Technologies LtdSASKEN | 62.4/100Mixed-positive evidence100% evidence | LEADER | 30.8/35 Revenue 67.8% · PAT 67.4% · OPM change 4 pp 100% evidence | 8.0/25 ROCE 9.9% · OPM 9% 100% evidence | 9.8/20 P/E 40.6× · PEG 0.68 100% evidence | 13.8/20 RS sector 22.8% · RS bench 27.4% · 1Y 37.2%12 of 12 weeks ahead 100% evidence |
| Exact sum: 30.8 + 8 + 9.8 + 13.8 = 62.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Sahana Systems LtdSAHANA | 62.4/100Mixed-positive evidence70% evidence | BASING | 21.5/35 Revenue 100% · PAT 100% · OPM change -3 pp 48% evidence | 19.9/25 ROCE 39.8% · OPM 29% 95% evidence | 14.5/20 P/E 12.3× · PEG — 50% evidence | 6.5/20 RS sector -19.6% · RS bench -3.1% · 1Y -33.9%0 of 12 weeks ahead 100% evidence |
| Exact sum: 21.5 + 19.9 + 14.5 + 6.5 = 62.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9String Metaverse Ltd534535 | 62.2/100Mixed-positive evidence82% evidence | BASING | 27.2/35 Revenue 100% · PAT 100% · OPM change 0 pp 95% evidence | 15.7/25 ROCE 41.6% · OPM 11% 76% evidence | 14.7/20 P/E 7.9× · PEG — 50% evidence | 4.6/20 RS sector -53.3% · RS bench -43.5% · 1Y -70.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 27.2 + 15.7 + 14.7 + 4.6 = 62.2 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -53.3% and the one-year return is -70.1%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 10TAC Infosec LtdTAC | 62.0/100Mixed-positive evidence66% evidence | ASLEEP | 25.6/35 Revenue 76.4% · PAT 59.4% · OPM change 1.6 pp 71% evidence | 20.9/25 ROCE 38.1% · OPM 48.2% 95% evidence | 9.3/20 P/E 35.3× · PEG — 15% evidence | 6.2/20 RS sector -12.3% · RS bench -20% · 1Y 4.7%1 of 10 weeks ahead 70% evidence |
| Exact sum: 25.6 + 20.9 + 9.3 + 6.2 = 62 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -12.3% and the one-year return is 4.7%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 11IZMO LtdIZMO | 60.8/100Mixed-positive evidence81% evidence | BREAKING OUT | 24.1/35 Revenue 24.7% · PAT 10.2% · OPM change 8 pp 95% evidence | 14.2/25 ROCE 12.6% · OPM 25% 95% evidence | 6.7/20 P/E 26.2× · PEG — 50% evidence | 15.8/20 RS sector 30.3% · RS bench 9.6% · 1Y 148.4%9 of 10 weeks ahead 70% evidence |
| Exact sum: 24.1 + 14.2 + 6.7 + 15.8 = 60.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12ASM Technologies LtdASMTEC | 60.8/100Mixed-positive evidence69% evidence | 28.1/35 Revenue 67.8% · PAT 89.5% · OPM change 2 pp 95% evidence | 16.4/25 ROCE 27% · OPM 23% 76% evidence | 8.7/20 P/E 91.8× · PEG — 15% evidence | 7.6/20 RS sector -5.8% · RS bench -18.4% · 1Y -22.1%0 of 12 weeks ahead to 2026-03-08 70% evidence | |
| Exact sum: 28.1 + 16.4 + 8.7 + 7.6 = 60.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13InfoBeans Technologies LtdINFOBEAN | 59.2/100Mixed-positive evidence87% evidence | TURNING | 26.5/35 Revenue 35.5% · PAT 60.4% · OPM change 0 pp 95% evidence | 16.9/25 ROCE 29.2% · OPM 21% 95% evidence | 9.6/20 P/E 18.5× · PEG — 50% evidence | 6.2/20 RS sector -8.1% · RS bench -4.1% · 1Y 14.9%5 of 12 weeks ahead 100% evidence |
| Exact sum: 26.5 + 16.9 + 9.6 + 6.2 = 59.2 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -8.1% and the one-year return is 14.9%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 14Softtech Engineers LtdSOFTTECH | 59.0/100Mixed-positive evidence80% evidence | FADING | 25.2/35 Revenue 35.8% · PAT 100% · OPM change -0.1 pp 95% evidence | 12.1/25 ROCE 6.2% · OPM 27.2% 95% evidence | 8.7/20 P/E 118× · PEG — 15% evidence | 13.0/20 RS sector 13.9% · RS bench 18% · 1Y 13.4%9 of 12 weeks ahead 100% evidence |
| Exact sum: 25.2 + 12.1 + 8.7 + 13 = 59 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Hypersoft Technologies LtdHYPERSOFT | 58.3/100Thin evidence · provisional52% evidence | 25.5/35 Revenue 100% · PAT 100% · OPM change 2.9 pp 71% evidence | 11.8/25 ROCE 20.6% · OPM 14% 76% evidence | 8.6/20 P/E 431× · PEG — 15% evidence | 12.4/20 RS sector — · RS bench 61.7% · 1Y 28.6%4 of 12 weeks ahead to 2026-03-08 25% evidence | |
| Exact sum: 25.5 + 11.8 + 8.6 + 12.4 = 58.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 16Infosys LtdINFY | 58.1/100Mixed-positive evidence82% evidence | TURNING | 18.2/35 Revenue 11.2% · PAT 11.1% · OPM change 0 pp 95% evidence | 20.1/25 ROCE 40% · OPM 24% 76% evidence | 14.0/20 P/E 15.2× · PEG — 50% evidence | 5.8/20 RS sector -18.7% · RS bench -15.8% · 1Y -17.8%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18.2 + 20.1 + 14 + 5.8 = 58.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17BLS E-Services LtdBLSE | 57.9/100Mixed-positive evidence75% evidence | LEADER | 18.8/35 Revenue 71.2% · PAT 9.4% · OPM change 0 pp 95% evidence | 10.5/25 ROCE 17% · OPM 7% 76% evidence | 9.0/20 P/E 49.1× · PEG — 15% evidence | 19.6/20 RS sector 48.9% · RS bench 54.1% · 1Y 72.6%12 of 12 weeks ahead 100% evidence |
| Exact sum: 18.8 + 10.5 + 9 + 19.6 = 57.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Saksoft LtdSAKSOFT | 57.7/100Mixed-positive evidence100% evidence | BREAKING OUT | 17.9/35 Revenue 8.2% · PAT 13% · OPM change 0 pp 100% evidence | 15.6/25 ROCE 25.5% · OPM 18% 100% evidence | 13.2/20 P/E 16.4× · PEG 0.6 100% evidence | 11.0/20 RS sector -7.5% · RS bench -4.8% · 1Y -23.6%9 of 12 weeks ahead 100% evidence |
| Exact sum: 17.9 + 15.6 + 13.2 + 11 = 57.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19Ksolves India LtdKSOLVES | 57.5/100Mixed-positive evidence87% evidence | BASING | 18.0/35 Revenue 16% · PAT 16.7% · OPM change 3.9 pp 95% evidence | 20.6/25 ROCE 131% · OPM 30.3% 95% evidence | 13.7/20 P/E 17.7× · PEG — 50% evidence | 5.2/20 RS sector -12% · RS bench -8.7% · 1Y -12.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18 + 20.6 + 13.7 + 5.2 = 57.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 20Expleo Solutions LtdEXPLEOSOL | 57.3/100Mixed-positive evidence81% evidence | ASLEEP | 20.9/35 Revenue 10.4% · PAT 39.4% · OPM change 4 pp 95% evidence | 15.8/25 ROCE 24.2% · OPM 15% 95% evidence | 13.8/20 P/E 8.6× · PEG — 50% evidence | 6.8/20 RS sector -12.4% · RS bench -11% · 1Y -26.7%3 of 10 weeks ahead 70% evidence |
| Exact sum: 20.9 + 15.8 + 13.8 + 6.8 = 57.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 21Subex LtdSUBEXLTD | 56.6/100Mixed-positive evidence65% evidence | BREAKING OUT | 24.4/35 Revenue 2.8% · PAT 100% · OPM change 13 pp 95% evidence | 10.3/25 ROCE 12.8% · OPM 19% 95% evidence | 9.9/20 P/E 24.2× · PEG — 15% evidence | 12.0/20 RS sector — · RS bench 21.2% · 1Y —5 of 5 weeks ahead 25% evidence |
| Exact sum: 24.4 + 10.3 + 9.9 + 12 = 56.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 22LTM LtdLTM | 56.3/100Mixed-positive evidence100% evidence | TURNING | 17.3/35 Revenue 13.9% · PAT 10% · OPM change 1 pp 100% evidence | 17.9/25 ROCE 29.6% · OPM 18% 100% evidence | 11.3/20 P/E 24.9× · PEG 1.18 100% evidence | 9.8/20 RS sector -9.8% · RS bench -6.8% · 1Y -5.9%1 of 12 weeks ahead 100% evidence |
| Exact sum: 17.3 + 17.9 + 11.3 + 9.8 = 56.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 23R Systems International LtdRSYSTEMS | 55.4/100Mixed-positive evidence100% evidence | ASLEEP | 18.8/35 Revenue 24.1% · PAT -1% · OPM change 3 pp 100% evidence | 16.4/25 ROCE 19.5% · OPM 18% 100% evidence | 18.2/20 P/E 13.6× · PEG 0.26 100% evidence | 2.0/20 RS sector -31.2% · RS bench -29.2% · 1Y -42.2%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18.8 + 16.4 + 18.2 + 2 = 55.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 24Tanla Platforms LtdTANLA | 53.7/100Mixed-positive evidence94% evidence | BREAKING OUT | 14.5/35 Revenue 13.2% · PAT 9.9% · OPM change 0 pp 100% evidence | 16.5/25 ROCE 26.3% · OPM 16% 100% evidence | 13.2/20 P/E 14.5× · PEG 1.21 100% evidence | 9.5/20 RS sector -11% · RS bench 4% · 1Y -5.9%9 of 10 weeks ahead 70% evidence |
| Exact sum: 14.5 + 16.5 + 13.2 + 9.5 = 53.7 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 25TechNVision Ventures LtdTECHNVISN | 53.3/100Mixed-positive evidence74% evidence | ASLEEP | 26.0/35 Revenue 23.4% · PAT 100% · OPM change 2.9 pp 95% evidence | 5.5/25 ROCE 12.9% · OPM 5.2% 95% evidence | 8.5/20 P/E 1093× · PEG — 15% evidence | 13.3/20 RS sector 32.1% · RS bench -7.8% · 1Y 30.3%0 of 7 weeks ahead 70% evidence |
| Exact sum: 26 + 5.5 + 8.5 + 13.3 = 53.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 26Danlaw Technologies India Ltd532329 | 53.2/100Mixed-positive evidence60% evidence | 15.7/35 Revenue 10.9% · PAT 14% · OPM change 0.8 pp 95% evidence | 15.5/25 ROCE 27.2% · OPM 13.4% 76% evidence | 9.6/20 P/E 26.6× · PEG — 15% evidence | 12.4/20 RS sector — · RS bench 65.9% · 1Y — 25% evidence | |
| Exact sum: 15.7 + 15.5 + 9.6 + 12.4 = 53.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 27Xchanging Solutions LtdXCHANGING | 52.8/100Mixed-positive evidence81% evidence | ASLEEP | 18.6/35 Revenue 8.4% · PAT 13.2% · OPM change 1 pp 95% evidence | 15.4/25 ROCE 18% · OPM 34% 95% evidence | 13.4/20 P/E 11.7× · PEG — 50% evidence | 5.4/20 RS sector -23.6% · RS bench -14.3% · 1Y -26%1 of 10 weeks ahead 70% evidence |
| Exact sum: 18.6 + 15.4 + 13.4 + 5.4 = 52.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 28Seshaasai Technologies LtdSTYL | 52.5/100Mixed-positive evidence73% evidence | BREAKING OUT | 12.8/35 Revenue 6.7% · PAT 20.6% · OPM change 0 pp 100% evidence | 17.1/25 ROCE 27.7% · OPM 23% 100% evidence | 12.6/20 P/E 25× · PEG 0.81 65% evidence | 10.0/20 RS sector — · RS bench — · 1Y —9 of 10 weeks ahead 0% evidence |
| Exact sum: 12.8 + 17.1 + 12.6 + 10 = 52.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 29Blue Cloud Softech Solutions LtdBLUECLOUDS | 52.5/100Mixed-positive evidence69% evidence | 22.0/35 Revenue 41.1% · PAT 36.2% · OPM change 10 pp 95% evidence | 12.8/25 ROCE 14.2% · OPM 20% 76% evidence | 9.4/20 P/E 32.9× · PEG — 15% evidence | 8.3/20 RS sector -3.8% · RS bench -16.1% · 1Y -24.4%1 of 12 weeks ahead to 2026-03-08 70% evidence | |
| Exact sum: 22 + 12.8 + 9.4 + 8.3 = 52.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 30AvenuesAI LtdCCAVENUE | 52.2/100Mixed-positive evidence93% evidence | BREAKING OUT | 21.0/35 Revenue 100% · PAT 43.8% · OPM change -2.3 pp 100% evidence | 8.1/25 ROCE 7.7% · OPM 3.7% 100% evidence | 15.1/20 P/E 18.1× · PEG 0.37 65% evidence | 8.0/20 RS sector -10.1% · RS bench -6.9% · 1Y 1.4%8 of 12 weeks ahead 100% evidence |
| Exact sum: 21 + 8.1 + 15.1 + 8 = 52.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 31Dynacons Systems & Solutions LtdDSSL | 52.2/100Mixed-positive evidence87% evidence | FADING | 16.9/35 Revenue 10.5% · PAT 16.2% · OPM change 3 pp 95% evidence | 15.4/25 ROCE 29.8% · OPM 13% 95% evidence | 7.9/20 P/E 18× · PEG — 50% evidence | 12.0/20 RS sector 5.1% · RS bench 9.4% · 1Y 20.4%10 of 12 weeks ahead 100% evidence |
| Exact sum: 16.9 + 15.4 + 7.9 + 12 = 52.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 32Birlasoft LtdBSOFT | 51.7/100Mixed-positive evidence100% evidence | BASING | 19.8/35 Revenue 1.4% · PAT 21.1% · OPM change 4 pp 100% evidence | 13.0/25 ROCE 21.2% · OPM 16% 100% evidence | 14.5/20 P/E 14.6× · PEG 0.62 100% evidence | 4.4/20 RS sector -19.6% · RS bench -16.4% · 1Y -16.2%0 of 12 weeks ahead 100% evidence |
| Exact sum: 19.8 + 13 + 14.5 + 4.4 = 51.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 33Tata Consultancy Services LtdTCS | 51.3/100Mixed-positive evidence100% evidence | TURNING | 10.2/35 Revenue 7.7% · PAT 1.1% · OPM change -1 pp 100% evidence | 22.5/25 ROCE 63% · OPM 26% 100% evidence | 11.9/20 P/E 15.9× · PEG 1.85 100% evidence | 6.7/20 RS sector -17.8% · RS bench -14.9% · 1Y -22.2%0 of 12 weeks ahead 100% evidence |
| Exact sum: 10.2 + 22.5 + 11.9 + 6.7 = 51.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 34HCL Technologies LtdHCLTECH | 50.6/100Mixed-positive evidence82% evidence | TURNING | 12.3/35 Revenue 12.6% · PAT 2.6% · OPM change 0 pp 95% evidence | 19.0/25 ROCE 30.4% · OPM 20% 76% evidence | 9.0/20 P/E 20.4× · PEG — 50% evidence | 10.3/20 RS sector -9% · RS bench -5.6% · 1Y -7.8%3 of 12 weeks ahead 100% evidence |
| Exact sum: 12.3 + 19 + 9 + 10.3 = 50.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 35Sonata Software LtdSONATSOFTW | 50.4/100Mixed-positive evidence97% evidence | BREAKING OUT | 9.4/35 Revenue 4% · PAT 7.9% · OPM change 0 pp 95% evidence | 13.6/25 ROCE 30.7% · OPM 5% 95% evidence | 12.9/20 P/E 18.1× · PEG 0.81 100% evidence | 14.5/20 RS sector -0.7% · RS bench 2.3% · 1Y -5%8 of 12 weeks ahead 100% evidence |
| Exact sum: 9.4 + 13.6 + 12.9 + 14.5 = 50.4 · Decision use: Price leads the evidence: RS versus the benchmark is 2.3%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 36Mastek LtdMASTEK | 50.4/100Mixed-positive evidence82% evidence | TURNING | 13.7/35 Revenue 6% · PAT 5% · OPM change 0 pp 95% evidence | 13.6/25 ROCE 18% · OPM 15% 76% evidence | 12.6/20 P/E 13× · PEG — 50% evidence | 10.5/20 RS sector -8.5% · RS bench -5.7% · 1Y -26.3%2 of 12 weeks ahead 100% evidence |
| Exact sum: 13.7 + 13.6 + 12.6 + 10.5 = 50.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 37RNIT AI Solutions LtdAUTOPALIND | 50.4/100Thin evidence · provisional55% evidence | TURNING | 16.8/35 Revenue 59.8% · PAT 66.7% · OPM change -0.6 pp 95% evidence | 14.6/25 ROCE 20.2% · OPM 35.3% 76% evidence | 9.0/20 P/E 51.8× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —4 of 12 weeks ahead 0% evidence |
| Exact sum: 16.8 + 14.6 + 9 + 10 = 50.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 38Capillary Technologies India LtdCAPILLARY | 50.3/100Mixed-positive evidence63% evidence | ASLEEP | 27.4/35 Revenue 27.8% · PAT 135.8% · OPM change 5.8 pp 100% evidence | 4.1/25 ROCE 3.4% · OPM 15.7% 100% evidence | 8.8/20 P/E 83.6× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —0 of 10 weeks ahead 0% evidence |
| Exact sum: 27.4 + 4.1 + 8.8 + 10 = 50.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 39Mphasis LtdMPHASIS | 50.0/100Mixed-positive evidence94% evidence | TURNING | 15.2/35 Revenue 13.7% · PAT 9.9% · OPM change -1 pp 100% evidence | 17.2/25 ROCE 22.1% · OPM 18% 100% evidence | 5.6/20 P/E 25.1× · PEG 2.19 100% evidence | 12.0/20 RS sector 1.1% · RS bench -1.5% · 1Y -5.6%2 of 10 weeks ahead 70% evidence |
| Exact sum: 15.2 + 17.2 + 5.6 + 12 = 50 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 40Hexaware Technologies LtdHEXT | 48.7/100Mixed-negative evidence94% evidence | BREAKING OUT | 14.3/35 Revenue 13% · PAT 1.2% · OPM change 4 pp 100% evidence | 17.7/25 ROCE 30.1% · OPM 16% 100% evidence | 10.7/20 P/E 24.6× · PEG 0.81 100% evidence | 6.0/20 RS sector -20.6% · RS bench -8.1% · 1Y -20.8%8 of 10 weeks ahead 70% evidence |
| Exact sum: 14.3 + 17.7 + 10.7 + 6 = 48.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 41Zensar Technologies LtdZENSARTECH | 47.7/100Mixed-negative evidence100% evidence | BASING | 15.8/35 Revenue 8% · PAT 15.3% · OPM change 0 pp 100% evidence | 13.6/25 ROCE 22.8% · OPM 15% 100% evidence | 13.8/20 P/E 14× · PEG 1.11 100% evidence | 4.5/20 RS sector -25.7% · RS bench -23.5% · 1Y -37.5%0 of 12 weeks ahead 100% evidence |
| Exact sum: 15.8 + 13.6 + 13.8 + 4.5 = 47.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 42XT Global Infotech LtdXTGLOBAL | 47.3/100Mixed-negative evidence61% evidence | 18.6/35 Revenue 85.4% · PAT 29.4% · OPM change -6.6 pp 53% evidence | 9.3/25 ROCE 7.5% · OPM 9.5% 71% evidence | 9.3/20 P/E 40.8× · PEG — 50% evidence | 10.1/20 RS sector 0% · RS bench -12.7% · 1Y -10.3%2 of 12 weeks ahead to 2026-03-29 70% evidence | |
| Exact sum: 18.6 + 9.3 + 9.3 + 10.1 = 47.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 43Unicommerce eSolutions LtdUNIECOM | 45.9/100Mixed-negative evidence74% evidence | BASING | 14.5/35 Revenue 38.4% · PAT 18.1% · OPM change -8.1 pp 95% evidence | 16.5/25 ROCE 21.1% · OPM 10.6% 95% evidence | 9.1/20 P/E 45.5× · PEG — 15% evidence | 5.8/20 RS sector -13.6% · RS bench -22.3% · 1Y -26.6%0 of 10 weeks ahead 70% evidence |
| Exact sum: 14.5 + 16.5 + 9.1 + 5.8 = 45.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 44Wipro LtdWIPRO | 44.7/100Mixed-negative evidence100% evidence | BASING | 12.9/35 Revenue 6.4% · PAT -1.7% · OPM change 0 pp 100% evidence | 15.0/25 ROCE 17.8% · OPM 19% 100% evidence | 13.2/20 P/E 13.8× · PEG 1.4 100% evidence | 3.6/20 RS sector -20.6% · RS bench -17.9% · 1Y -23%0 of 12 weeks ahead 100% evidence |
| Exact sum: 12.9 + 15 + 13.2 + 3.6 = 44.7 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 45Excelsoft Technologies LtdEXCELSOFT | 44.6/100Mixed-negative evidence60% evidence | ASLEEP | 12.0/35 Revenue 26.8% · PAT 4.2% · OPM change -1.8 pp 95% evidence | 12.1/25 ROCE 13.6% · OPM 16.3% 95% evidence | 10.5/20 P/E 17× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —1 of 10 weeks ahead 0% evidence |
| Exact sum: 12 + 12.1 + 10.5 + 10 = 44.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4663 Moons Technologies Ltd63MOONS | 42.3/100Thin evidence · provisional58% evidence | BREAKING OUT | 20.6/35 Revenue 100% · PAT -80% · OPM change 128 pp 71% evidence | 3.4/25 ROCE -3.7% · OPM -52% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 8.3/20 RS sector -21.5% · RS bench 6.9% · 1Y -13.9%8 of 11 weeks ahead 70% evidence |
| Exact sum: 20.6 + 3.4 + 10 + 8.3 = 42.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 47Innovana Thinklabs LtdINNOVANA | 39.2/100Mixed-negative evidence81% evidence | ASLEEP | 8.7/35 Revenue 26% · PAT -39% · OPM change -32.5 pp 95% evidence | 11.6/25 ROCE 16.4% · OPM 17.6% 95% evidence | 9.4/20 P/E 21.4× · PEG — 50% evidence | 9.5/20 RS sector 0.7% · RS bench -22.9% · 1Y -38.9%0 of 10 weeks ahead 70% evidence |
| Exact sum: 8.7 + 11.6 + 9.4 + 9.5 = 39.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 48Magellanic Cloud LtdMCLOUD | 38.7/100Mixed-negative evidence81% evidence | TURNING | 9.7/35 Revenue 13.7% · PAT 6.7% · OPM change -7 pp 95% evidence | 13.9/25 ROCE 19.8% · OPM 28% 95% evidence | 11.8/20 P/E 15× · PEG — 50% evidence | 3.3/20 RS sector -54% · RS bench -26.3% · 1Y -67.2%6 of 11 weeks ahead 70% evidence |
| Exact sum: 9.7 + 13.9 + 11.8 + 3.3 = 38.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 49Aurionpro Solutions LtdAURIONPRO | 37.6/100Mixed-negative evidence93% evidence | BASING | 13.1/35 Revenue 14.8% · PAT 5.1% · OPM change -3 pp 100% evidence | 10.6/25 ROCE 16.3% · OPM 17% 100% evidence | 9.9/20 P/E 19.4× · PEG 1.39 65% evidence | 4.0/20 RS sector -28.3% · RS bench -26.1% · 1Y -47.6%2 of 12 weeks ahead 100% evidence |
| Exact sum: 13.1 + 10.6 + 9.9 + 4 = 37.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 50Allied Digital Services LtdADSL | 35.5/100Mixed-negative evidence74% evidence | ASLEEP | 14.4/35 Revenue 19.1% · PAT 5.6% · OPM change 0 pp 95% evidence | 6.3/25 ROCE 7.4% · OPM 9% 95% evidence | 10.6/20 P/E 16.4× · PEG — 15% evidence | 4.2/20 RS sector -29.1% · RS bench -20.2% · 1Y -31.9%4 of 10 weeks ahead 70% evidence |
| Exact sum: 14.4 + 6.3 + 10.6 + 4.2 = 35.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 51Kellton Tech Solutions LtdKELLTONTEC | 34.2/100Adverse evidence87% evidence | ASLEEP | 10.0/35 Revenue 9.5% · PAT 9.6% · OPM change -1 pp 95% evidence | 9.7/25 ROCE 15% · OPM 11% 95% evidence | 11.8/20 P/E 8× · PEG — 50% evidence | 2.7/20 RS sector -28.3% · RS bench -26.2% · 1Y -46.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 10 + 9.7 + 11.8 + 2.7 = 34.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 52Mindteck (India) LtdMINDTECK | 32.6/100Adverse evidence87% evidence | ASLEEP | 7.9/35 Revenue -1.8% · PAT 0.3% · OPM change -1.7 pp 95% evidence | 10.4/25 ROCE 15.1% · OPM 7.8% 95% evidence | 11.7/20 P/E 17.2× · PEG — 50% evidence | 2.6/20 RS sector -20.5% · RS bench -17.6% · 1Y -5.9%5 of 12 weeks ahead 100% evidence |
| Exact sum: 7.9 + 10.4 + 11.7 + 2.6 = 32.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 53Moschip Technologies LtdMOSCHIP | 30.7/100Adverse evidence87% evidence | FADING | 7.7/35 Revenue 8.4% · PAT -33.6% · OPM change -3.9 pp 100% evidence | 7.0/25 ROCE 11% · OPM 8.2% 100% evidence | 3.6/20 P/E 127× · PEG 5.04 65% evidence | 12.4/20 RS sector 3% · RS bench -3.1% · 1Y 32.5%7 of 10 weeks ahead 70% evidence |
| Exact sum: 7.7 + 7 + 3.6 + 12.4 = 30.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 54Orient Technologies LtdORIENTTECH | 29.7/100Thin evidence · provisional54% evidence | ASLEEP | 15.1/35 Revenue — · PAT — · OPM change -0.5 pp 19% evidence | 2.4/25 ROCE 8.4% · OPM 6.7% 95% evidence | 9.0/20 P/E 47.2× · PEG — 15% evidence | 3.2/20 RS sector -20% · RS bench -17.2% · 1Y -7.2%0 of 12 weeks ahead 100% evidence |
| Exact sum: 15.1 + 2.4 + 9 + 3.2 = 29.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 55Quick Heal Technologies LtdQUICKHEAL | 18.8/100Adverse evidence69% evidence | ASLEEP | 6.2/35 Revenue -6.6% · PAT -80% · OPM change -22.1 pp 71% evidence | 1.8/25 ROCE -4.7% · OPM -39% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 0.8/20 RS sector -35.9% · RS bench -34.5% · 1Y -47.7%6 of 12 weeks ahead 100% evidence |
| Exact sum: 6.2 + 1.8 + 10 + 0.8 = 18.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 56Covance Softsol Ltd544361 | 67.0/100Thin evidence · provisional49% evidence | 25.8/35 Revenue 43.5% · PAT 100% · OPM change 19.7 pp 62% evidence | 17.8/25 ROCE 31.4% · OPM 23.1% 76% evidence | 11.2/20 P/E 12.9× · PEG — 15% evidence | 12.2/20 RS sector — · RS bench 48.4% · 1Y — 25% evidence | |
| Exact sum: 25.8 + 17.8 + 11.2 + 12.2 = 67 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 57Exato Technologies Ltd544626 | 57.9/100Thin evidence · provisional38% evidence | 20.9/35 Revenue — · PAT — · OPM change 3.4 pp 45% evidence | 17.5/25 ROCE 26.8% · OPM 18% 76% evidence | 9.5/20 P/E 32.6× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y — 0% evidence | |
| Exact sum: 20.9 + 17.5 + 9.5 + 10 = 57.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 58Unified Data- Tech Solutions LtdUNIFIED | 55.9/100Thin evidence · provisional31% evidence | 16.9/35 Revenue — · PAT — · OPM change 1 pp 26% evidence | 18.8/25 ROCE 45.2% · OPM 15% 76% evidence | 10.2/20 P/E 18.6× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y 14.8%0 of 12 weeks ahead to 2026-03-08 0% evidence | |
| Exact sum: 16.9 + 18.8 + 10.2 + 10 = 55.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 59Metalic Technoforge LtdMETA | 53.0/100Thin evidence · provisional27% evidence | 16.2/35 Revenue — · PAT — · OPM change -2 pp 13% evidence | 17.1/25 ROCE 36.1% · OPM 8% 76% evidence | 9.7/20 P/E 25.3× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y -42.1%0 of 12 weeks ahead to 2026-03-08 0% evidence | |
| Exact sum: 16.2 + 17.1 + 9.7 + 10 = 53 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 60Kody Technolab LtdKODYTECH | 52.7/100Thin evidence · provisional48% evidence | BREAKING OUT | 15.2/35 Revenue — · PAT — · OPM change -5 pp 19% evidence | 13.1/25 ROCE 16.8% · OPM 29% 95% evidence | 8.7/20 P/E 119× · PEG — 15% evidence | 15.7/20 RS sector 11.5% · RS bench 59.2% · 1Y 84.6%8 of 10 weeks ahead 70% evidence |
| Exact sum: 15.2 + 13.1 + 8.7 + 15.7 = 52.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 61Trident Techlabs LtdTECHLABS | 46.1/100Thin evidence · provisional40% evidence | 16.0/35 Revenue — · PAT — · OPM change -2 pp 15% evidence | 16.1/25 ROCE 26.7% · OPM 27% 71% evidence | 10.8/20 P/E 14.9× · PEG — 15% evidence | 3.2/20 RS sector -49.7% · RS bench -56.5% · 1Y -60%0 of 12 weeks ahead to 2026-03-29 70% evidence | |
| Exact sum: 16 + 16.1 + 10.8 + 3.2 = 46.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 62Veefin Solutions LtdVEEFIN | 45.3/100Thin evidence · provisional43% evidence | 17.7/35 Revenue — · PAT — · OPM change -5.1 pp 19% evidence | 10.6/25 ROCE 9.8% · OPM 19.7% 76% evidence | 9.6/20 P/E 27.7× · PEG — 15% evidence | 7.4/20 RS sector -7.2% · RS bench -18.7% · 1Y -24.3%0 of 12 weeks ahead to 2026-03-08 70% evidence | |
| Exact sum: 17.7 + 10.6 + 9.6 + 7.4 = 45.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 63ERP Soft Systems Ltdthis page530909 | 44.3/100Thin evidence · provisional41% evidence | 19.8/35 Revenue 19.1% · PAT 100% · OPM change -1.1 pp 53% evidence | 8.0/25 ROCE 1.6% · OPM 1.7% 57% evidence | 8.9/20 P/E 74.9× · PEG — 15% evidence | 7.6/20 RS sector — · RS bench -47.6% · 1Y -55%0 of 12 weeks ahead to 2026-03-29 25% evidence | |
| Exact sum: 19.8 + 8 + 8.9 + 7.6 = 44.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 64IDream Film Infrastructure Company Ltd504375 | 38.4/100Thin evidence · provisional35% evidence | TURNING | 12.8/35 Revenue — · PAT 0% · OPM change — 33% evidence | 3.1/25 ROCE -9.2% · OPM -25.8% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 12.5/20 RS sector — · RS bench 117.6% · 1Y —6 of 6 weeks ahead 25% evidence |
| Exact sum: 12.8 + 3.1 + 10 + 12.5 = 38.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is ERP Soft Systems Ltd's share price today?
ERP Soft Systems Ltd trades at ₹47.3, −63.6% over the past year. The company is valued at ₹18.7 Cr. The stock sits at 3% of its 52-week range of ₹44–₹144, −47.7% versus its 200-day average. On the tape, the price is in a downtrend, 32 weeks in. — as of 14 August 2026.
What were ERP Soft Systems Ltd's latest quarterly results?
ERP Soft Systems Ltd reported revenue of ₹2.4 Cr and net profit of ₹0.0 Cr for the Dec 25 quarter. Revenue fell 7.5% and profit fell 25.0% year on year. Earnings per share were ₹0.08. The operating margin was 1.7%, 1.1 pp lower than a year earlier. — as of 14 August 2026.
What is ERP Soft Systems Ltd's revenue?
ERP Soft Systems Ltd reported revenue of ₹2.4 Cr in the Dec 25 quarter, −7.5% year on year. For the full FY25 fiscal year, revenue was ₹9.7 Cr (−17.5%). Over the last 10 years revenue compounded at −4.2% a year. — as of 14 August 2026.
What is ERP Soft Systems Ltd's profit?
ERP Soft Systems Ltd earned ₹0.0 Cr of net profit in the Dec 25 quarter, −25.0% year on year. Full-year FY25 profit was ₹0.2 Cr. The operating margin ran 1.7% in the latest quarter. — as of 14 August 2026.
What is ERP Soft Systems Ltd's market cap?
ERP Soft Systems Ltd's market capitalisation is ₹18.7 Cr at a share price of ₹47.3. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 14 August 2026.
What is ERP Soft Systems Ltd's P/E ratio?
ERP Soft Systems Ltd trades at a P/E of 74.9×, at the 16th percentile of its own 9-year range, against a long-run median of 151.5×. This is a comparison with the stock's own history, not a value call — as of 14 August 2026.
Does ERP Soft Systems Ltd pay a dividend?
No — ERP Soft Systems Ltd has recorded a dividend payout of 0% of profit in each of its last 12 reported fiscal years, so there is no payout history to quote. That is a reading of the filed annual statements, not an estimate. — as of 14 August 2026.
Is ERP Soft Systems Ltd overvalued?
On its own history, ERP Soft Systems Ltd looks cheap: its P/E of 74.9× has been cheaper only 16% of the time in 9 years (long-run median 151.5×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 14 August 2026.
Is ERP Soft Systems Ltd growing?
Not right now — ERP Soft Systems Ltd's latest numbers are shrinking: latest-quarter revenue −7.5% year on year, profit −25.0%, and the margin −1.1 pp at 1.7%. The 10-year compound rates are −4.2% (revenue) and −7.8% (profit). The earnings engine currently reads: deteriorating — as of 14 August 2026.
How is ERP Soft Systems Ltd performing?
ERP Soft Systems Ltd is in a downtrend, 32 weeks in. Its latest quarter's revenue fell 7.5% and profit fell 25.0% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 50 weeks. This describes what the data did, not a rating. — as of 14 August 2026.
What stage is ERP Soft Systems Ltd in?
Mixed — no clean majority across the growth curves, ROCE holding at 1.6% — the per-curve reads carry the story. The read comes from the last 12 quarters of growth (revenue growth −7.5% latest, profit growth −25.0% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 14 August 2026.
Is ERP Soft Systems Ltd in an uptrend?
No — the price is in a downtrend (week 32 of stage 4), trading −47.7% versus its 200-day average and at 3% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 14 August 2026.
Is ERP Soft Systems Ltd beating the market?
Not lately — on a trailing-13-week view ERP Soft Systems Ltd is currently behind the NIFTY 500 (50 weeks and counting; last ahead the week of 2025-04-04), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 9.2 years the stock moved −32% against the NIFTY 500's +179% — behind the index over the full window. — as of 14 August 2026.
Will ERP Soft Systems Ltd's share price go up?
This page publishes no price forecast for ERP Soft Systems Ltd. What it measures instead: the share price is ₹47.3, the price is in a downtrend 32 weeks in. Its P/E of 74.9× sits at the 16th percentile of its own 9-year range. — as of 14 August 2026.
Who owns ERP Soft Systems Ltd?
Promoters hold 55.8% of ERP Soft Systems Ltd, foreign institutions null%, domestic institutions null% and the public 44.2% (latest quarter). No holder moved a full point over the last two years — the register is quiet. — as of 14 August 2026.
Does ERP Soft Systems Ltd have too much debt?
No — ERP Soft Systems Ltd's debt-to-equity is 0.11, and operating profit covers the interest bill 9×. FY25 borrowings were ₹1.9 Cr against equity of ₹18.1 Cr. The returns on this page are earned, not borrowed — as of 14 August 2026.
What is ERP Soft Systems Ltd's capex?
ERP Soft Systems Ltd spent ₹0.0 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was ₹0.0 Cr, with ₹0.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 14 August 2026.
What is ERP Soft Systems Ltd's cash flow?
ERP Soft Systems Ltd generated ₹0.7 Cr of operating cash flow in FY25 and ₹1.0 Cr of free cash flow after ₹0.0 Cr of capital spending. Reported profit that year was ₹0.2 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 14 August 2026.
Is ERP Soft Systems Ltd's profit real cash?
Yes — over the last 3 fiscal years, 82% of ERP Soft Systems Ltd's reported profit arrived as operating cash. In FY25, operating cash was ₹0.7 Cr against reported profit of ₹0.2 Cr. The cash then goes into a mix of the working-capital cycle and capacity. Cash-flow resolution is annual — as of 14 August 2026.
Where is ERP Soft Systems Ltd in its business cycle?
ERP Soft Systems Ltd's FY25 operating margin was 2.8%, against a 12-year band of −5.1%–4.7%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 1.7%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 14 August 2026.
What growth does ERP Soft Systems Ltd's price assume?
At its price on 13 June 2026, ERP Soft Systems Ltd was priced for profit growth of about 37.0% a year. Profit itself has compounded −7.8% a year over the past 10 years. The figure reads the multiple backwards: the growth a buyer at that price was already paying for. — as of 14 August 2026.
What could break the ERP Soft Systems Ltd story?
The sharpest disagreement: annual EPS moved +11.6% against a −63.6% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 14 August 2026.
Is ERP Soft Systems Ltd a stock worth studying right now?
This is not investment advice. The machine read: ERP Soft Systems Ltd is cheap for a reason. The P/E sits at the 16th percentile of its own range, and the quarters are still getting worse. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 14 August 2026.